Drug
Alectinib
Alectinib: highest development phase Phase 2, developed by Roche. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Alectinib NCT04302025 | Phase 2 | Non-small Cell Lung Cancer |
| Alectinib NCT01984229 | Phase 1 | Healthy Volunteer |
Latest
No recent events.
Follow Alectinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.